SCHEMBL24970907

SCHEMBL24970907

CC(C)COCCOC(C)(COc1cccc(C(=O)NCCNC(C)C)c1)SSC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KAT6A Q92794 2/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ NR1H4 Q96RI1 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ TAAR1 Q96RJ0 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ MAOB P27338 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ ADRB2 P07550 1/20 0.36
▸ ADRB1 P08588 1/20 0.36
▸ ADRB3 P13945 1/20 0.36
▸ CHRM2 P08172 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ TP53BP1 Q12888 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24849637 0.93 ALDH1A1 (0.36) KMT2AALDH1A1MEN1TAAR1LMNA
SCHEMBL24972998 0.93 GAA (0.42) KAT6AKMT2ANR1H4ALDH1A1MAOB
SCHEMBL26049672 0.92 ALDH1A1 (0.46) KMT2AALDH1A1MEN1TAAR1LMNA
SCHEMBL22327237 0.91 ALDH1A1 (0.37) KMT2AALDH1A1MEN1TAAR1LMNA
SCHEMBL26068748 0.91 MAPT (0.43) KAT6AKMT2ANR1H4ALDH1A1MEN1
SCHEMBL24972999 0.91 KAT6A (0.40) KAT6AKMT2ANR1H4ALDH1A1MEN1
SCHEMBL22327421 0.89 MAOB (0.38) KAT6AKMT2ANR1H4ALDH1A1LMNA
SCHEMBL26068684 0.86 GAA (0.41) KAT6AKMT2AALDH1A1MEN1TAAR1
SCHEMBL22327267 0.85 GAA (0.44) KMT2AALDH1A1MEN1TAAR1MAOB
SCHEMBL22598234 0.85 MAOB (0.35) KMT2AALDH1A1MEN1TAAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257414-A1 NUCLEOTIDE ANALOGUES FIRST-CITIZENS BANK & TRUST COMPANY 2023-08-17 — — US disclosed
US-20230203083-A1 NUCLEOTIDE ANALOGUES FIRST-CITIZENS BANK & TRUST COMPANY 2023-06-29 — — US disclosed
US-20230028359-A1 NUCLEOTIDE ANALOGUES FIRST-CITIZENS BANK & TRUST COMPANY 2023-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257414-A1 NUCLEOTIDE ANALOGUES ITPA, POLB, NUDT1 KAT6A 2123/4885KMT2A 1334/4885NR1H4 3934/4885
US-20230028359-A1 NUCLEOTIDE ANALOGUES ITPA, POLB, NUDT1 KAT6A 2123/4885KMT2A 1334/4885NR1H4 3934/4885
US-20230203083-A1 NUCLEOTIDE ANALOGUES ITPA, POLB, NUDT1 KAT6A 2123/4885KMT2A 1334/4885NR1H4 3934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback